Utilizing social media for subject recruitment - 2 Ten, LLC

564 views

Published on

How to use social media to attract, recruit and retain volunteers and patients for Phase I-IV clinical trials.

Published in: Marketing, Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
564
On SlideShare
0
From Embeds
0
Number of Embeds
10
Actions
Shares
0
Downloads
5
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Utilizing social media for subject recruitment - 2 Ten, LLC

  1. 1. Utilizing Social Media to Reach & Recruit Phase I-IV Clinical Trial Subjects Jared Byer, MBA Principal 2 Ten, LLC
  2. 2. Social Media Defined • Internet-based applications that build on the technological foundations of Web 2.0  Springboard for social outreach to support engagement among people, organizations and communities
  3. 3. Leading Platforms • Websites (CMS) • Facebook − 1.5 billion users • Twitter − 500 million total users; 215M active users • LinkedIn − 259 million users • YouTube − 1 billion users
  4. 4. U.S. Regulatory Agencies • No social media policies published by FDA – Due no later than July 2014 • FDA Office of Prescription Drug Promotion (OPDP) – Has taken actions against companies alleged to have posted misleading promotions on Facebook and YouTube
  5. 5. Above All • Protect patient, study, Investigator, IP – Remember: Platforms support 2-way communications – Control flow to assure privacy & protection
  6. 6. Solutions: Social Marketing • Attract and engage by providing relevant, timely content that empowers the audience and defines the community  Websites, blogs, articles, white papers, videos, webinars, etc. • Impartial, reliable, consistent
  7. 7. Create Community • Website – Patient-centric network provides accurate, relevant information that empowers patients and caregivers   Focused Extended via Twitter, LinkedIn, Facebook, YouTube, links to related websites
  8. 8. Create Community • Website – Each page presents links that allow reader to continue relationship  Request additional info about disease, treatment options, studies, etc.  Voluntarily enter network • Control engagement; protect privacy
  9. 9. Questions? Jared Byer, MBA Principal 2 Ten, LLC jared@2tenllc.com 913.980.0028

×